Rafael Holdings RFL
NYSE RFL
$1.53 +0.03 (+2.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rafael Holdings (RFL) Gains from Investment Securities (2019)

Updated

Rafael Holdings' Gains from Investment Securities came in at -$466,000 for fiscal Q3 2019 (quarter ended Apr 30, 2019).

Analysis

Rafael Holdings (RFL) Gains from Investment Securities (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Rafael Holdings 78.35 Mn 83.76 Mn 163,000.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2019 -466,000.00
Jan 31, 2019 148,000.00
API Access

Rafael Holdings Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=RFL&period=max&api_key=YOUR_API_KEY